Inhibition of intratracheal lung cancer development by systemic delivery of E1A

Oncogene

Volumn 13, Issue 7, 1996, Pages 1405-1412

  Chang, Joe Yujiao ^a   Xia, Weiya ^a   Shao, Ruping ^a   Hung, Mien Chie ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Adenoviral vector; EIA; Gene therapy; HER 2 neu; Lung cancer

Indexed keywords

VIRUS PROTEIN;

ADENOVIRUS 5; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; COLONY FORMATION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; LUNG CANCER; NONHUMAN; ONCOGENE NEU; PRIORITY JOURNAL;

ADENOVIRUS E1A PROTEINS; ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; DEFECTIVE VIRUSES; GENE THERAPY; GENES, VIRAL; GENETIC VECTORS; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RECEPTOR, ERBB-2; TRACHEA; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

ADENOVIRIDAE; ANIMALIA; HUMAN ADENOVIRUS TYPE 5;

EID: 0029845632     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Bargmann CI, Hung MC and Weinberg RA. (1986). Nature, 319, 226 - 230.
2. Berchuck A, Kamel A, Whitake R, Kerns B, Olt G, Kinney R, Soper JT, Dodge R, Clarke-Pearson DL, Marks P, McKenzie S, Yin S and Bast RC. (1990). Cancer Res., 50, 4087 - 4091.
3. Byrd PJ, Grand RJA and Gallimore PH. (1988). Oncogene, 2, 477 - 484.
4. Chinnadurai G. (1992). Oncogene, 7, 1255 - 1258.
5. Coussens L, Yang-Feng TL, Laio YC, Chen E, Gray A, McGrath J, Seeburg PH, Libermann TA, Schlessinger J, Francke U, Levinson UFA and Ullrich A. (1985). Science, 230, 1132 - 1139.
6. Davenport EA, Drobes BL, Menke SL and Tushar TB. (1988). Anticancer Res., 8, 957 - 970.
7. Frisch SM. (1991). Proc. Natl. Acad. Sci. USA, 88, 9077 - 9081.
8. Frisch SM and Francis HJ. (1994). J. Cell Biol., 124, 619 - 626.
9. Frisch SM and Dolter KE. (1995). Cancer Res., 55, 5551 - 5555.
10. Graham FL and Smiley J. (1977). J. Gen. Virol., 36, 59 - 72.
11. Graham FL and Prevec L. (1991). Methods in Molecular Biology: Gene Transfer and Expression Protocols. Murray EJ. (ed). Human Press Inc: Clifton NJ, pp. 109 - 128.
12. Houweling A, Van Den Elsen PJ and Van Der Eb AJ. (1980). Virology, 105, 537 - 550.
13. Hung MC, Matin A, Zhang YJ, Xing X, Sorgi F, Huang L and Yu D. (1995). Gene, 159, 65 - 71.
14. Kast WC, Offringa R, Peters PJ, Voordouw AC, Meloen RH, Van Der Eb AJ and Melief JM. (1989). Cell, 59, 603 - 614
15. Kern JA, Schwartz DA, Nordberg JE, Weiner DB, Greene MI, Torney L and Robinson RA. (1990). Cancer Res., 50, 5284 - 5291.
16. Knowles MR, Hohnker KW, Zhou Z, Olsen JC and Noah TL. (1995). New Eng. J. Med., 333 823 - 831.
17. Lesoon-Wood L, Kim WH, Kleinman HK, Weintraub BD and Mixson AJ. (1995). Hum. Gene Ther., 6, 395 - 405.
18. Minna J, Pass H, Glatstein E and Ihde D. (1989). Cancer: Principles and Practice of Oncology, 3rd Ed. Devita Jr V. Hellman S and Rosenberg S. (eds). JB Lippincott: Philadelphia, pp. 591 - 705.
19. Perera FP, Santella R, Brandt-Rauf PW, Kahn S, Jiang W and Mayer J. (1991). Origins of human cancer: a comprehensive review. Brugge T, Curran T, Harlow E and McCormick H (eds). Cold Spring Harbor Laboratory: NY, pp. 219 - 236.
20. Pozzatti R, McCormick M, Thompson MA and Khoury G. (1988). Mol. Cell. Biol., 8, 2984 - 2988.
21. Ruley HE. (1983). Nature, 304, 602 - 606.
22. Schneider R, Hung MC, Chiocca SM, Manning J, Zhao X, Fang H and Roth JA. (1989). Cancer Res., 49, 4968 - 4971.
23. Shi D, He G, Cao S, Pan W, Zhang HZ, Yu D and Hung MC. (1992). Mol. Carcinogenesis, 5, 213 - 218.
24. Simon RH, Engelhardt JF, Yang Y, Zepeda M, Weberpendleton S, Grossman M and Wilson JM. (1993). Human Gene Therapy, 4, 771 - 780.
25. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. (1987). Science, 23, 177 - 182.
26. Thierry AR, Lunardi-Iskandar Y, Bryant JL, Brabinovich P, Gallo RC and Mahan LC. (1995). Proc. Natl. Acad. Sci. USA, 92, 9742 - 9746.
27. Tsai CM, Chang KT, Perng RP, Mitsudomi T, Chen MH and Gazdar AF. (1993). J. Natl. Cancer Inst., 85, 897 - 901.
28. Tsai CM, Yu D, Chang KT, Wu LH, Perng RP, Ibrahim NK and Hung MC. (1995). J. Natl. Cancer Inst., 87, 682 - 684.
29. Weinberg RA. (1989). Cancer Res., 49, 3713 - 3721.
30. Yamamoto T, Ikawa S, Akiyama KS, Nomura N, Miyajima N, Saito T and Toyoshima K. (1986). Nature, 319, 230 - 232.
31. Yang Y, Nunes FA, Berencsi K, Gonczol E, Engelhart JF and Wilson JM. (1994). Nature Genetics, 7, 362 - 369.
32. Yu D and Hung MC. (1991). Oncogene, 6, 1991 - 1996.
33. Yu D, Hamada JI, Zhang H, Nicolson GL and Hung MC. (1992). Oncogene, 7, 2263 - 2270.
34. Yu D, Scorsone K and Hung MC. (1991). Mol. und Cell. Biol., 11, 1745 - 1750.
35. Yu D, Suen TC, Yan DH, Chang LS and Hung MC. (1990). Proc. Natl. Acad. Sci. USA, 87, 4499 - 4503.
36. Yu D, Wang SS, Dulski KM, Tsai CM, Nicolson GL and Hung MC. (1994). Cancer Res., 54, 3260 - 3266.
37. Yu D, Matin A, Xia WY, Sorgi F, Huang L and Hung MC. (1995). Oncogene, 11, 1383 - 1388.
38. Zhang YJ, Yu D, Xia WY and Hung MC. (1995). Oncogene, 10, 2263 - 2270.